CapForce IBD 50 ETF
FFTY
64 hedge funds and large institutions have $50.8M invested in CapForce IBD 50 ETF in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 10 closing their positions.
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
10% more capital invested
Capital invested by funds: $46.4M → $50.8M (+$4.45M)
5% more funds holding
Funds holding: 61 → 64 (+3)
0.1% more ownership
Funds ownership: 24.41% → 24.51% (+0.1%)
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
Top Buyers
Top Sellers
FFTY Hedge Fund Activity: Q4 2020 in Review
64 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in CapForce IBD 50 ETF (FFTY) for Q4 2020, worth a combined $50.8M — up 9.6% from $46.4M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new FFTY positions and 10 closed out — a net gain of 4 holders — while 13 added to existing stakes and 19 trimmed.
The largest buyer was Cetera Investment Advisers, opening a new position worth an estimated $1.83M. The largest seller was Osaic Holdings, cutting an estimated $2.5M.
- 64 institutional investors held CapForce IBD 50 ETF (FFTY) as of Q4 2020, up from 61 in Q3 2020.
- Funds reported $50.8M of CapForce IBD 50 ETF stock for Q4 2020, up 9.6% quarter-over-quarter.
- 14 funds opened new CapForce IBD 50 ETF positions in Q4 2020 and 10 closed out, a net change of +4 holders.
- The largest CapForce IBD 50 ETF buyer in Q4 2020 was Cetera Investment Advisers, an estimated $1.83M added.
- The largest CapForce IBD 50 ETF seller in Q4 2020 was Osaic Holdings, an estimated $2.5M sold.
Based on aggregated 13F filings for Q4 2020.